Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Kauffman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Chemistry|May 26, 2023
Effective therapy with Bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor modelsNathan Kauffman, Satyendra Kumar Singh, James Morrison, et al.
Pharmaceutics|April 28, 2023
Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle TherapeuticsNathan Kauffman, James Morrison, Kevin O'Brien, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2025
<sup>212</sup>Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell RepopulationSatyendra Kumar Singh, Nathan Kauffman, Isabelle Maria Lynch, et al.
Frontiers in Chemistry|February 9, 2024
Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse modelsAbdullah Metebi, Nathan Kauffman, Lu Xu, et al.
Molecular Imaging and Biology|April 30, 2025
Species-Specific Hepatic Uptake of [<sup>64</sup>Cu]Cu-EOB-NOTA, A Newly Designed Hepatospecific PET AgentJinda Fan, Bijja Janaki Ramulu, Christiane L Mallett, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Chemistry|May 26, 2023
Effective therapy with Bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor modelsNathan Kauffman, Satyendra Kumar Singh, James Morrison, et al.
Pharmaceutics|April 28, 2023
Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle TherapeuticsNathan Kauffman, James Morrison, Kevin O'Brien, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2025
<sup>212</sup>Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell RepopulationSatyendra Kumar Singh, Nathan Kauffman, Isabelle Maria Lynch, et al.
Frontiers in Chemistry|February 9, 2024
Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse modelsAbdullah Metebi, Nathan Kauffman, Lu Xu, et al.
Molecular Imaging and Biology|April 30, 2025
Species-Specific Hepatic Uptake of [<sup>64</sup>Cu]Cu-EOB-NOTA, A Newly Designed Hepatospecific PET AgentJinda Fan, Bijja Janaki Ramulu, Christiane L Mallett, et al.
Pageof 1